Literature DB >> 7590626

Physiological effect of glucagon in human isolated adipocytes.

A Perea1, F Clemente, J Martinell, M L Villanueva-Peñacarrillo, I Valverde.   

Abstract

In human isolated adipocytes, glucagon induces a dose dependent increment of the glycerol release, which is already observed at physiological concentrations of the hormone. Furthermore, glucagon at 10(-8) M, significantly stimulates the adenylate cyclase activity in both non-solubilized and solubilized fat plasma membranes, and at already 10(-11) M, a significant increment of the adipocyte cAMP content is observed. These data support previous in vivo positive results indicating that glucagon plays a role in human fat metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590626     DOI: 10.1055/s-2007-979981

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  21 in total

1.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  The alpha-cell as target for type 2 diabetes therapy.

Authors:  Mikkel Christensen; Jonatan I Bagger; Tina Vilsbøll; Filip K Knop
Journal:  Rev Diabet Stud       Date:  2011-11-10

3.  White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism.

Authors:  Michael S Hofman; Rodney J Hicks
Journal:  EJNMMI Res       Date:  2011-06-07       Impact factor: 3.138

Review 4.  Regulation of lipolysis in adipocytes.

Authors:  Robin E Duncan; Maryam Ahmadian; Kathy Jaworski; Eszter Sarkadi-Nagy; Hei Sook Sul
Journal:  Annu Rev Nutr       Date:  2007       Impact factor: 11.848

Review 5.  The metabolic actions of glucagon revisited.

Authors:  Kirk M Habegger; Kristy M Heppner; Nori Geary; Timothy J Bartness; Richard DiMarchi; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

Review 6.  Metabolic implications of pancreatic fat accumulation.

Authors:  Robert Wagner; Sabine S Eckstein; Hajime Yamazaki; Felicia Gerst; Jürgen Machann; Benjamin Assad Jaghutriz; Annette Schürmann; Michele Solimena; Stephan Singer; Alfred Königsrainer; Andreas L Birkenfeld; Hans-Ulrich Häring; Andreas Fritsche; Susanne Ullrich; Martin Heni
Journal:  Nat Rev Endocrinol       Date:  2021-10-20       Impact factor: 43.330

7.  Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte.

Authors:  Kirk M Habegger
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

8.  Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

Authors:  A M Arafat; P Kaczmarek; M Skrzypski; E Pruszyńska-Oszmalek; P Kołodziejski; D Szczepankiewicz; M Sassek; T Wojciechowicz; B Wiedenmann; A F H Pfeiffer; K W Nowak; M Z Strowski
Journal:  Diabetologia       Date:  2012-12-22       Impact factor: 10.122

9.  Gut-derived serotonin is a multifunctional determinant to fasting adaptation.

Authors:  Grzegorz Sumara; Olga Sumara; Jason K Kim; Gerard Karsenty
Journal:  Cell Metab       Date:  2012-10-18       Impact factor: 27.287

10.  Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.

Authors:  Joanne A Hoogerland; Fabian Peeks; Brenda S Hijmans; Justina C Wolters; Sander Kooijman; Trijnie Bos; Aycha Bleeker; Theo H van Dijk; Henk Wolters; Albert Gerding; Karen van Eunen; Rick Havinga; Amanda C M Pronk; Patrick C N Rensen; Gilles Mithieux; Fabienne Rajas; Folkert Kuipers; Dirk-Jan Reijngoud; Terry G J Derks; Maaike H Oosterveer
Journal:  J Inherit Metab Dis       Date:  2021-04-07       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.